Related Experiment Video
Updated: Aug 15, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea
Si Hyun Bae1, Seung Kew Yoon, Jeong Won Jang
1Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.
Insights
Hepatitis B virus (HBV) genotype C is predominant in Korean chronic liver disease patients. This finding was consistent across asymptomatic carriers and those with advanced liver conditions like cirrhosis and cancer.
Area of Science:
- Hepatology
- Virology
- Genetics
Background:
- Hepatitis B virus (HBV) causes chronic liver disease globally and in Korea.
- HBV is classified into genotypes with distinct geographic distributions.
- Limited data exist on HBV genotype relevance to clinical outcomes in Korea.
Purpose of the Study:
- To investigate the clinical features associated with HBV genotypes in Korea.
- To determine the prevalence of HBV genotypes among different stages of chronic liver disease.
Main Methods:
- Collected 120 serum samples from chronic HBV carriers in Korea.
- Classified patients into asymptomatic carrier (ASC), chronic hepatitis (CH), liver cirrhosis (LC), and hepatocellular carcinoma (HCC).
- Determined HBV genotype using ELISA and direct sequencing of the small S gene.
Main Results:
- HBV genotypes were determined in 105 (87.5%) samples.
- HBV genotype C was identified in all patients across ASC, CH, LC, and HCC stages.
- Genotypes A, B, D, E, F, and G were not detected.
Conclusions:
- HBV genotype C is the predominant genotype among chronic carriers in Korea.
- Genotype C prevalence is consistent irrespective of clinical stage or geographic origin within Korea.
Abstract:
Hepatitis B virus (HBV) is one of the major causative agents of chronic liver diseases in Korea. HBV has been classified into 8 genotypes by a divergence of >8% in the entire genomic sequence, and have distinct geographic distributions. There are limited data on the relevance between HBV genotypes and clinical outcomes in Korea. To investigate the clinical feature relating to HBV genotype in Korea, a total 120 serum samples with HBsAg (65 from Seoul and 55 from the other city in Korea) were obtained from each 30 chronic HBV carriers with asymptomatic carrier (ASC), chronic hepatitis (CH), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). HBV genotype was determined by either enzyme-linked immunosorbent assay (ELISA) using monoclonal antibodies against genotype-specific epitopes in the preS2-region or the direct sequencing of small S gene. HBV genotypes were determined in 105 (87.5%) of 120 samples. HBV genotype C was identified in all HBV carriers with ASC, CH, LC, and HCC. Genotypes A, B, D, E, F and G were not detected in any of them. Genotype C HBV prevails predominantly among chronic carriers of the virus in Korea, irrespective of their clinical stages of liver disease and geographic origin.
Related Concept Videos
Hepatitis
Cytomegalovirus Disease
Viral Hepatitis I: Introduction
Genital Herpes
Viruses with RNA Genomes
Retroviruses
